Axsome Therapeutics, Inc. (AXSM)
137.01
-4.68
(-3.30%)
USD |
NASDAQ |
Nov 16, 16:00
135.01
-2.00
(-1.46%)
After-Hours: 06:30
Axsome Therapeutics Price to Book Value : 68.32 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 68.32 |
| November 13, 2026 | 70.66 |
| November 12, 2026 | 71.99 |
| November 11, 2026 | 74.42 |
| November 10, 2026 | 70.30 |
| November 09, 2026 | 66.80 |
| November 06, 2026 | 66.01 |
| November 05, 2026 | 64.73 |
| November 04, 2026 | 68.32 |
| November 03, 2026 | 69.62 |
| November 02, 2026 | 67.82 |
| October 30, 2026 | 72.02 |
| October 29, 2026 | 71.53 |
| October 28, 2026 | 71.56 |
| October 27, 2026 | 70.91 |
| October 26, 2026 | 71.84 |
| October 23, 2026 | 72.33 |
| October 22, 2026 | 77.83 |
| October 21, 2026 | 77.95 |
| October 20, 2026 | 79.58 |
| October 19, 2026 | 77.70 |
| October 16, 2026 | 78.36 |
| October 15, 2026 | 80.68 |
| October 14, 2026 | 80.89 |
| October 13, 2026 | 77.95 |
| Date | Value |
|---|---|
| October 12, 2026 | 82.78 |
| October 09, 2026 | 83.95 |
| October 08, 2026 | 84.81 |
| October 07, 2026 | 86.26 |
| October 06, 2026 | 86.94 |
| October 05, 2026 | 88.30 |
| October 02, 2026 | 89.39 |
| October 01, 2026 | 90.79 |
| September 30, 2026 | 91.95 |
| September 29, 2026 | 116.86 |
| September 28, 2026 | 121.73 |
| September 25, 2026 | 122.48 |
| September 24, 2026 | 123.07 |
| September 23, 2026 | 121.45 |
| September 22, 2026 | 127.51 |
| September 21, 2026 | 129.01 |
| September 18, 2026 | 130.45 |
| September 17, 2026 | 134.53 |
| September 16, 2026 | 133.08 |
| September 15, 2026 | 128.12 |
| September 14, 2026 | 135.97 |
| September 11, 2026 | 138.59 |
| September 10, 2026 | 132.54 |
| September 09, 2026 | 132.24 |
| September 08, 2026 | 130.47 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 33.46 |
| Filana Therapeutics, Inc. | 0.4059 |
| CorMedix, Inc. | 0.8297 |
| Eloxx Pharmaceuticals, Inc. | 1.269 |
| Breakthrough Chemistry, Inc. | 1.592 |
Price to Book Value Related Metrics
| PS Ratio | 8.158 |
| Price | 137.01 |
| Earnings Yield | -2.23% |
| Market Cap | 7.204B |